↓ Skip to main content

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability

Overview of attention for article published in Clinical and Translational Medicine, February 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
26 Mendeley
Title
Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
Published in
Clinical and Translational Medicine, February 2013
DOI 10.1186/2001-1326-2-7
Pubmed ID
Authors

Charlotte Welinder, Göran Jönsson, Christian Ingvar, Lotta Lundgren, Håkan Olsson, Thomas Breslin, Ákos Végvári, Thomas Laurell, Melinda Rezeli, Bo Jansson, Bo Baldetorp, György Marko‐Varga

Abstract

The objectives and goals of the Southern Swedish Malignant Melanoma (SSMM) are to develop, build and utilize cutting edge biobanks and OMICS platforms to better understand disease pathology and drug mechanisms. The SSMM research team is a truly cross-functional group with members from oncology, surgery, bioinformatics, proteomics, and genomics initiatives. Within the research team there are members who daily diagnose patients with suspect melanomas, do follow-ups on malignant melanoma patients and remove primary or metastatic lesions by surgery. This inter-disciplinary clinical patient care ensures a competence build as well as a best practice procedure where the patient benefits.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 4%
Denmark 1 4%
Unknown 24 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 31%
Student > Bachelor 3 12%
Student > Ph. D. Student 3 12%
Other 2 8%
Student > Doctoral Student 1 4%
Other 4 15%
Unknown 5 19%
Readers by discipline Count As %
Medicine and Dentistry 5 19%
Engineering 3 12%
Computer Science 3 12%
Agricultural and Biological Sciences 3 12%
Biochemistry, Genetics and Molecular Biology 2 8%
Other 5 19%
Unknown 5 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2013.
All research outputs
#13,599,723
of 15,414,857 outputs
Outputs from Clinical and Translational Medicine
#202
of 243 outputs
Outputs of similar age
#128,852
of 150,988 outputs
Outputs of similar age from Clinical and Translational Medicine
#1
of 1 outputs
Altmetric has tracked 15,414,857 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 243 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 150,988 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them